PERK inhibitors function by blocking the kinase activity of PERK, which is necessary for its role in phosphorylating the eukaryotic initiation factor 2 alpha (eIF2α). Phosphorylation of eIF2α leads to a reduction in global protein synthesis, allowing cells to cope with stress. Inhibiting this process forces cancer cells to accumulate misfolded proteins, leading to cellular stress and apoptosis.
